Jump to content
RemedySpot.com

Medivir: TMC435 has Received Fast Track Designation from the FDA and TMC435 will be studied in combination with Pharmasset's PSI-7977 for HCV genotype-1

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 11

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Medivir: TMC435 has Received Fast Track Designation from the FDA and TMC435

will be studied in combination with Pharmasset's PSI-7977 for HCV genotype-1

From the PharmaLive.com News Archive - Jul. 06, 2011

Medivir today announced that its investigational protease inhibitor TMC435

has received “Fast Track” designation by the FDA for the treatment of chronic

hepatitis C (CHC) genotype-1 infection. This is based on TMC435's potential to

address unmet medical needs in the treatment of CHC infection compared to

currently approved therapies.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...